// App-Quantinova.ai

575 : Human serine protease therapeutics- potent constructs targeting Fn14 in multiple tumor types

Researchers

Presenter

  • Ana Alvarez-Cienfuegos

Principal Investigators

  • Lawrence H. Cheung

  • Khalid A. Mohamedali

  • Yunli Zhao

  • Kathryn E. Ruisaard

  • Jeffrey A. Winkles

  • Michael G. Rosenblum

Medical Centers

  • 1.MD Anderson Cancer Center, Houston, TX

  • Shenyang Pharmaceutical University, China.

  • University of Maryland School of Medicine, Baltimore, MD

Locations

  • United States

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • DNA Damage Inducible Transcript 3

  • Granzyme B

  • TNF superfamily member 12

  • Tumor necrosis factor

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Pharmacokinetics

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved